Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.

R.M. Nijmeijer, R.M. Gadaleta, S.W. van Mil, A.A. van Bodegraven, J.B.A. Crusius, G. Dijkstra, D.W. Hommes, DJ de Jong, P.C. Stokkers, H.W. Verspaget, R.K. Weersma, C.J. van der Woude, J.M. Stapelbroek, M.E. Schipper, C. Wijmenga, K.J. Erpecum, B. Oldenburg

Research output: Contribution to journalArticleAcademicpeer-review

60 Downloads (Pure)
Original languageEnglish
Article numbere23745
JournalPLoS ONE
Volume6
Issue number8
DOIs
Publication statusPublished - 2011

Cite this

Nijmeijer, R. M., Gadaleta, R. M., van Mil, S. W., van Bodegraven, A. A., Crusius, J. B. A., Dijkstra, G., ... Oldenburg, B. (2011). Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease. PLoS ONE, 6(8), [e23745]. https://doi.org/10.1371/journal.pone.0023745